retatrutide clinical trial outcomes Targeting the weight within: obesity pharmacotherapy in cardiovascular disease Retatrutide, Eli Lilly's next generation

This makes it an ideal complement to Supresa in the Lemme GLP-1 formula, creating a comprehensive approach to metabolic support and weight management

These gaps represent opportunities where complementary peptides shine

2026 Mar 12;19(3):463

In 2025, the Medicines and Healthcare products Regulatory Agency (MHRA) seized 5,851 counterfeit or unlicensed weight loss injections in the UK, and around 4,000 of those were retatrutide

The state spent nearly $298 million, or about $106 per enrollee, for these drugs from November 2023 to this past October, according to new data from Real Chemistry

BPC157 is an experimental but promising therapy for dogs with joint, gut, or tissue healing needs